Cargando…

Acute high-risk pulmonary embolism requiring thrombolytic therapy in a COVID-19 pneumonia patient despite intermediate dosing deep vein thromboprophylaxis

Cytokine storm induced by the coronavirus 19 (COVID-19) profoundly activates the coagulation cascade causing venous thromboembolism (VTE). Initial studies from Wuhan, China showed increased incidence of VTE in patients with no standard deep vein thrombosis (DVT) prophylaxis in COVID-19 pneumonia pat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Salam, Shameen, Mallat, Jihad, Elkambergy, Hussam
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2020
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7560270/ https://www.ncbi.nlm.nih.gov/pubmed/33083223 http://dx.doi.org/10.1016/j.rmcr.2020.101263

Ejemplares similares

Characteristics of critically ill patients infected with COVID-19 in Abu Dhabi, United Arab Emirates
por: Abdallah, Khaled, et al.
Publicado: (2020)

Intermediate dose thromboprophylaxis in SARS-CoV-2 related venous thrombo embolism
por: Haider, Zahra, et al.
Publicado: (2021)

Effects of Methylprednisolone on Ventilator-Free Days in Mechanically Ventilated Patients with Acute Respiratory Distress Syndrome and COVID-19: A Retrospective Study
por: Badr, Mohamed, et al.
Publicado: (2021)

Thromboprophylaxis for Deep Vein Thrombosis and Pulmonary Embolism after Total Joint Arthroplasty in a Low Incidence Population
por: Kim, Kang-Il, et al.
Publicado: (2013)

Low-dose thrombolytic therapy versus unfractionated heparin in patients with intermediate-high risk pulmonary embolism
por: Surgit, Ozgur, et al.
Publicado: (2023)

Severe Acute Kidney Injury in Critically Ill Patients with COVID-19 Admitted to ICU: Incidence, Risk Factors, and Outcomes
por: Ghosn, Muriel, et al.
Publicado: (2021)

Late-onset of pulmonary embolism following hospitalization for COVID-19 despite thromboprophylaxis: a report of two cases
por: Brem, Falmata Laouan, et al.
Publicado: (2021)

Anti-FXa Activity with Intermediate-Dose Thromboprophylaxis in COVID-19
por: Rappaport, Stephen H., et al.
Publicado: (2020)

Deep vein thrombosis and thromboprophylaxis in arthroscopic anterior cruciate ligament reconstruction
por: Adala, Raviraj, et al.
Publicado: (2011)

Thrombolytic therapy in submassive pulmonary embolism
por: Özlek, Eda, et al.
Publicado: (2017)

Low-dose urokinase thrombolytic therapy for patients with acute intermediate-high-risk pulmonary embolism: A retrospective cohort study
por: Weng, Cuilian, et al.
Publicado: (2021)

New Thrombolytic Infusion Application of Dissolving Renal Artery Embolic Thrombosis: Low-Dose Slow-Infusion Thrombolytic Therapy
por: Karakurt, Ahmet
Publicado: (2018)

A Case of Massive Pulmonary Embolism Following Varicose Vein Surgery That Was Successfully Treated with Thrombolytic Therapy
por: Baha, Ayse, et al.
Publicado: (2017)

Incidence of deep vein thrombosis among non‐ICU patients hospitalized for COVID‐19 despite pharmacological thromboprophylaxis: Response from original authors Pola et al
por: Porfidia, Angelo, et al.
Publicado: (2020)

Comparing different thrombolytic dosing regimens for treatment of acute pulmonary embolism
por: Ghanem, Ammar, et al.
Publicado: (2010)

Thromboprophylaxis in routine arthroscopy of knee
por: Abouali, Jihad, et al.
Publicado: (2013)

Percutaneous thrombectomy in patients with intermediate- and high-risk pulmonary embolism and contraindications to thrombolytics: a systematic review and meta-analysis
por: Milioglou, Ioannis, et al.
Publicado: (2022)

Obstructive shock in pulmonary embolism: thrombolytic therapy and survival
por: Pivetti, S, et al.
Publicado: (1999)

Thrombolytic and anticoagulant therapy for acute submassive pulmonary embolism
por: FEI, JIANWEN, et al.
Publicado: (2014)

Mechanical thromboprophylaxis is sufficient to prevent the lower extremity deep vein thrombosis after kidney transplantation
por: Jun, Kang-Woong, et al.
Publicado: (2014)

Deep Vein Thrombosis and Pulmonary Embolism: Two Complications of COVID-19 Pneumonia?
por: Poggiali, Erika, et al.
Publicado: (2020)

Thrombolytic Recanalization of Carotid Arteries Is Highly Dependent on Degree of Stenosis, Despite Sonothrombolysis
por: Tomkins, Amelia J., et al.
Publicado: (2016)

Thromboprophylaxis in lower limb varicose vein surgery in Brazil
por: Ribeiro, Alcides José Araújo, et al.
Publicado: (2022)

Understanding haemorrhagic risk following thrombolytic therapy in patients with intermediate-risk and high-risk pulmonary embolism: a hypothesis paper
por: Abraham, Paul, et al.
Publicado: (2018)

Systemic thrombolysis with newer thrombolytics vs anticoagulation in acute intermediate risk pulmonary embolism: a systematic review and meta-analysis
por: Mathew, Don, et al.
Publicado: (2023)

Local thrombolytic therapy for primary axillosubclavian vein thrombosis
por: Maund, Isabella, et al.
Publicado: (2010)

Convalescent Plasma Efficacy in Life-Threatening COVID-19 Patients Admitted to the ICU: A Retrospective Cohort Study
por: Abuzakouk, Mohamed, et al.
Publicado: (2021)

Non‐severe COVID‐19 is associated with endothelial damage and hypercoagulability despite pharmacological thromboprophylaxis
por: Kelliher, Sarah, et al.
Publicado: (2022)

Reply to Rappaport et al.: Anti-FXa Activity with Intermediate-Dose Thromboprophylaxis in COVID-19
por: Dutt, Tina, et al.
Publicado: (2020)

Successful thrombolytic therapy for massive pulmonary embolism following abdominoplasty
por: Kolady, Jayakrishnan, et al.
Publicado: (2013)

The Role of Thrombolytic Therapy for Patients with a Submassive Pulmonary Embolism
por: Murphy, Elizabeth, et al.
Publicado: (2018)

Clinical Observation of Uninterrupted Thrombolytic Therapy via Indwelling Catheter for Lower Limb Deep Vein Thrombosis
por: Liu, Haoyuan, et al.
Publicado: (2023)

Bilateral renal vein thrombosis and pulmonary embolism secondary to membranous glomerulonephritis treated with percutaneous catheter thrombectomy and localized thrombolytic therapy
por: Janda, S. P.
Publicado: (2010)

COVID-19 Is Associated with Endothelial Dysfunction and Enhanced Plasma Thrombin Generation Despite Pharmacological Thromboprophylaxis
por: Kelliher, Sarah, et al.
Publicado: (2021)

Incidence and Nature of Lower-Limb Deep Vein Thrombosis in Patients with Polytrauma on Thromboprophylaxis: A Prospective Cohort Study
por: Chowdhury, Sharfuddin, et al.
Publicado: (2021)

Thromboprophylaxis in people hospitalized with COVID‐19: Assessing intermediate or standard doses in a retrospective cohort study
por: Andersen, Kathleen M., et al.
Publicado: (2022)

Massive Pulmonary Embolism and Deep Vein Thrombosis in COVID-19 Pneumonia: Two Case Reports
por: Chopra, Siddharth, et al.
Publicado: (2021)

Original approach for thrombolytic therapy in patients with Ilio-femoral deep vein thrombosis : 2 years follow-up
por: Fiengo, Leslie, et al.
Publicado: (2015)

Nomogram Prediction for Lower Extremity Deep Vein Thrombosis in Acute Ischemic Stroke Patients Receiving Thrombolytic Therapy
por: Wang, Yuyan, et al.
Publicado: (2023)

Cerebral Embolism Associated with Left Atrial Myxoma That Was Treated with Thrombolytic Therapy
por: Kohno, Naoto, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_vcn85jd7pm5cfoulu3gk5mri6n